Suchergebnisse - "Li, Chunna"

PubPharm (50)

31

Dolutegravir plus lamivudine versus efavirenz plus tenofovir disoproxil fumarate and lamivudine in antiretroviral-naive adults with HIV-1 infection

enthalten in: BMC infectious diseases | 2022

von Deng, L. | Li, C. | Chen, P. | +6

32

Application of wogonin in preparation of acetyltransferase inhibitor, crotonylation inhibitor and latent accelerant

enthalten in: Europäisches Patentamt | 2021

von XIA JINYU | HONG ZHONGSI | ZHANG HAITAO | +8

33

The epidemic of Q fever in 2018 to 2019 in Zhuhai city of China determined by metagenomic next-generation sequencing

enthalten in: PLoS neglected tropical diseases | 2021

von Huang, M. | Ma, J. | Jiao, J. | +21

34

OX40L/OX40 Signal Promotes IL-9 Production by Mucosal MAIT Cells During Helicobacter pylori Infection

enthalten in: Frontiers in immunology | 2021

von Ming, S. | Zhang, M. | Liang, Z. | +10

35

Design of Rehabilitation Training System for Pelvic Floor Dysfunction

in: SHS Web of Conferences | 2021

von Liu Yongfeng | Li Chunna | Zhong Jun | +2

36

Evidence for gastrointestinal infection of SARS-CoV-2

enthalten in: bioRxiv.org | 2020

von Xiao, F. | Tang, M. | Zheng, X. | +17

37

Rapid Fulminant Progression and Mortality Secondary to Aeromonas dhakensis Septicemia with Hepatitis B Virus Infection Following the Ingestion of Snakehead Fish in Mainland China : A Case Report

enthalten in: Foodborne pathogens and disease | 2020

von Huang, M. | Chen, H. | Li, C. | +9

38

SALT OF ALDOSE REDUCTASE INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF

enthalten in: Europäisches Patentamt | 2020

von YANG ZHANKUN | YANG HANYU | LI PENGFEI | +5

39

SALT OF ALDOSE REDUCTASE INHIBITOR, AND PREPARATION METHOD AND APPLICATION THEREOF

enthalten in: Europäisches Patentamt | 2020

von YANG ZHANKUN | YANG HANYU | LI PENGFEI | +5

40

Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019 : A retrospective cohort study

enthalten in: The Journal of infection | 2020

von Deng, L. | Li, C. | Zeng, Q. | +5